Login / Signup

Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson's disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD).

Taku HatanoGenko OyamaYasushi ShimoKotaro OgakiNoriko NishikawaJiro FukaeRyota NakamuraNaohide KuritaTaiji TsunemiYutaka OjiShinji SaikiKenya NishiokaHaruka Takeshige-AmanoDaisuke TaniguchiTakashi OgawaHikaru KamoHiroto EguchiAtsuhito FuseAsuka NakajimaMasayoshi KanoSho NakajimaNaotake YanagisawaNobutaka Hattori
Published in: BMJ open (2022)
JPRN-jRCTs031200172; Pre-results.
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • study protocol
  • phase iii
  • phase ii
  • phase ii study
  • irritable bowel syndrome
  • randomized controlled trial
  • open label
  • squamous cell carcinoma